빈포세틴

Vinpocetine, cognition, and epilepsy.

1. Epilepsy Behav. 2021 Jun;119:107988. doi: 10.1016/j.yebeh.2021.107988. Epub 2021 May 3. Vinpocetine, cognition, and epilepsy. Meador KJ(1), Leeman-Markowski B(2), Medina AE(3), Illamola SM(4), Seliger J(5), Novak G(6), Lin C(7), Ivanisevic M(8), Razavi B(9), Marino S(10), Boyd A(11), Loring

Vinpocetine increases the microsporicidal effect of albendazole on Encephalitozoon intestinalis.

2. Med Mycol. 2024 Aug 2;62(8):myae072. doi: 10.1093/mmy/myae072. Vinpocetine increases the microsporicidal effect of albendazole on Encephalitozoon intestinalis. Sezer G(1)(2), Çetinkaya Ü(2)(3). Author information: (1)Department of Pharmacology, Faculty of Medicine, Erciyes University, 38039

[Choice of neuroprotective therapy regimens in patients with chronic cerebral ischemia, taking into account the synergy of drug interactions].

3. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(8):42-50. doi: 10.17116/jnevro202012008142. [Choice of neuroprotective therapy regimens in patients with chronic cerebral ischemia, taking into account the synergy of drug interactions]. [Article in Russian; Abstract available in Russian from the

Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study.

4. Biomed Res Int. 2014;2014:324307. doi: 10.1155/2014/324307. Epub 2014 Dec 7. Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study. Alkuraishy HM(1), Al-Gareeb AI(1), Albuhadilly AK(2). Author information: (

Early alcohol exposure disrupts visual cortex plasticity in mice.

5. Int J Dev Neurosci. 2012 Aug;30(5):351-7. doi: 10.1016/j.ijdevneu.2012.05.001. Epub 2012 May 14. Early alcohol exposure disrupts visual cortex plasticity in mice. Lantz CL(1), Wang W, Medina AE. Author information: (1)Department of Anatomy and Neurobiology, School of Medicine, Virginia Commo

Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats.

6. Pharmacol Rep. 2011;63(5):1258-63. doi: 10.1016/s1734-1140(11)70648-x. Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats. Sozański T(1), Magdalan J, Trocha M, Szumny A, Merwid-Ląd A, Słupski W, Karaźniewicz-Łada M, Kiełbowicz G, Ksiądzyna D, Szeląg

Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs.

7. Epilepsy Res. 2011 Oct;96(3):257-66. doi: 10.1016/j.eplepsyres.2011.06.006. Epub 2011 Jul 7. Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs. Sitges M(1), Sanchez-Tafolla BM, Chiu LM, Aldana BI, Guarneros A.

Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs.

8. Drugs Today (Barc). 2010 Apr;46(4):265-77. doi: 10.1358/dot.2010.46.4.1445795. Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs. Vohora D(1), Saraogi P, Yazdani MA, Bhowmik M, Khanam R, Pillai KK. Author information:

Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine.

9. Clin Neurophysiol. 2008 Nov;119(11):2608-14. doi: 10.1016/j.clinph.2008.08.009. Epub 2008 Sep 30. Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine. Nekrassov V(1), Sitges M. Author information: (1

Effects of Vinpocetine on mitochondrial function and neuroprotection in primary cortical neurons.

10. Neurochem Int. 2008 Dec;53(6-8):289-95. doi: 10.1016/j.neuint.2008.08.003. Epub 2008 Aug 28. Effects of Vinpocetine on mitochondrial function and neuroprotection in primary cortical neurons. Tárnok K(1), Kiss E, Luiten PG, Nyakas C, Tihanyi K, Schlett K, Eisel UL. Author information: (1)Dep

Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release.

11. Neuropharmacology. 2007 Dec;53(7):854-62. doi: 10.1016/j.neuropharm.2007.08.016. Epub 2007 Aug 26. Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the

Efficacy and safety of herbal medicine on dementia and cognitive function: An umbrella review of systematic reviews and meta-analysis.

12. Phytother Res. 2023 Jun;37(6):2364-2380. doi: 10.1002/ptr.7759. Epub 2023 Feb 2. Efficacy and safety of herbal medicine on dementia and cognitive function: An umbrella review of systematic reviews and meta-analysis. Sawangjit R(1)(2), Chuenchom C(1), Sanverm T(1), Chaiyakunapruk N(3), Jiranuk

Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

13. Neurocrit Care. 2022 Aug;37(1):314-325. doi: 10.1007/s12028-022-01499-y. Epub 2022 Apr 29. Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Panda PK(#)(1), Ramachandran A(#)(2), Panda P(3), Sharawat IK(4). Author

Medications and Prescribing Patterns as Factors Associated with Hospitalizations from Long-Term Care Facilities: A Systematic Review.

14. Drugs Aging. 2018 May;35(5):423-457. doi: 10.1007/s40266-018-0537-3. Medications and Prescribing Patterns as Factors Associated with Hospitalizations from Long-Term Care Facilities: A Systematic Review. Wang KN(1), Bell JS(2)(3)(4), Chen EYH(2)(3), Gilmartin-Thomas JFM(4)(5), Ilomäki J(2)(4)

Vinpocetine for acute ischaemic stroke.

15. Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD000480. doi: 10.1002/14651858.CD000480.pub2. Vinpocetine for acute ischaemic stroke. Bereczki D(1), Fekete I. Author information: (1)Semmelweis University, Department of Neurology, Balassa u. 6., Budapest, Hungary, H-1083. bereczki@neur.sote

Vinpocetine for cognitive impairment and dementia.

3. Cochrane Database Syst Rev. 2003;2003(1):CD003119. doi: 10.1002/14651858.CD003119. Vinpocetine for cognitive impairment and dementia. Szatmari SZ(1), Whitehouse PJ. Author information: (1)4300, Targu Mures, str. Gral I., Dumitrache 22, Romania. szatmari@netsoft.ro BACKGROUND: Vinpocetine is

Vinpocetine for acute ischaemic stroke.

31. Cochrane Database Syst Rev. 2000;(2):CD000480. doi: 10.1002/14651858.CD000480. Vinpocetine for acute ischaemic stroke. Bereczki D(1), Fekete I. Author information: (1)Department of Neurology, University Medical School of Debrecen, Nagyerdei krt. 98, Debrecen, Hungary, H-4012. bereczki@jaguar

A systematic review of vinpocetine therapy in acute ischaemic stroke.

29. Eur J Clin Pharmacol. 1999 Jul;55(5):349-52. doi: 10.1007/s002280050639. A systematic review of vinpocetine therapy in acute ischaemic stroke. Bereczki D(1), Fekete I. Author information: (1)Department of Neurology, University Medical School of Debrecen, Hungary. bereczki@jaguar.dote.hu OBJ